CD34 and Epstein-Barr virus infection: Therefore, we will outline protocols for CD34+ human hematopoietic progenitor cell isolation and characterization, human immune system reconstitution in immune compromised mice, recombinant EBV production and humanized mouse infection, viral load and EBV‐associated lymphoma characterization, and basic T‐cell characterization in response to EBV infection.